Predicted protein targets (top 20)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 3/20 | 0.45 |
| ▸ | TSHR | P16473 | 2/20 | 0.45 |
| ▸ | MAPT | P10636 | 4/20 | 0.40 |
| ▸ | GAA | P10253 | 3/20 | 0.40 |
| ▸ | SMN1; SMN2 | Q16637 | 2/20 | 0.40 |
| ▸ | CA1 | P00915 | 1/20 | 0.36 |
| ▸ | CA2 | P00918 | 1/20 | 0.36 |
| ▸ | NPC1 | O15118 | 1/20 | 0.36 |
| ▸ | RAB9A | P51151 | 1/20 | 0.36 |
| ▸ | ALDH1A1 | P00352 | 4/20 | 0.34 |
| ▸ | POLB | P06746 | 1/20 | 0.34 |
| ▸ | CHRNB2 | P17787 | 1/20 | 0.34 |
| ▸ | CHRNA4 | P43681 | 1/20 | 0.34 |
| ▸ | HTT | P42858 | 2/20 | 0.34 |
| ▸ | MEN1 | O00255 | 1/20 | 0.33 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.33 |
| ▸ | LMNA | P02545 | 1/20 | 0.33 |
| ▸ | ALOX12 | P18054 | 1/20 | 0.33 |
| ▸ | L3MBTL1 | Q9Y468 | 1/20 | 0.33 |
| ▸ | ALOX15 | P16050 | 2/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL7583374 | 0.80 | TP53 (0.41) | CYP3A4TSHRNPC1RAB9AALDH1A1 | |
| SCHEMBL1539261 | 0.77 | NPC1 (0.36) | MAPTSMN1; SMN2NPC1RAB9AALDH1A1 | |
| SCHEMBL21962283 | 0.77 | KDM1A (0.35) | MAPTGAANPC1ALDH1A1CHRNB2 | |
| SCHEMBL30739381 | 0.77 | CHRNB2 (0.34) | MAPTGAACA1CA2ALDH1A1 | |
| SCHEMBL3792282 | 0.74 | CYP3A4 (0.50) | CYP3A4TSHRMAPTGAASMN1; SMN2 | |
| SCHEMBL7090123 | 0.73 | KDM4E (0.42) | TSHRMAPTGAASMN1; SMN2NPC1 | |
| SCHEMBL3202257 | 0.73 | KIF11 (0.38) | SMN1; SMN2NPC1RAB9AALDH1A1LMNA | |
| SCHEMBL29045096 | 0.72 | DRD2 (0.46) | — | |
| SCHEMBL3214155 | 0.71 | KMT2A (0.49) | TSHRGAASMN1; SMN2NPC1RAB9A | |
| SCHEMBL3786817 | 0.71 | CYP3A4 (0.46) | CYP3A4TSHRMAPTSMN1; SMN2CA1 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 13 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | KLINTZ RALF (DE) | 2001-10-18 | — | — | US | disclosed |
| US-6239074-B1 | HERBICIDES, INSECTICIDES | BASF AKTIENGESELLSCHAFT (DE) | 2001-05-29 | — | — | US | disclosed |
| US-5914351-A | Anti-viral aromatic hydrazones | UNIROYAL CHEMICAL COMPANY, INC. (US) | 1999-06-22 | — | — | US | disclosed |
| EP-0414112-B1 | Herbicides thiadiazabicyclononan derivatives | BASF AG (DE) | 1995-12-20 | — | — | EP | disclosed |
| EP-0400427-B1 | Herbicidal 5-(N-3,4,5,6-tetrahydrophthalimido)-cinnamic acid esters, process for their preparation and their use | BASF AG (DE) | 1995-04-05 | — | — | EP | disclosed |
| EP-0604491-A1 | SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES | BASF Aktiengesellschaft (DE) | 1994-07-06 | — | — | EP | disclosed |
| WO-1993006090-A1 | SUBSTITUTED 3-PHENYLURACILS AS HERBICIDES | BASF AKTIENGESELLSCHAFT (DE) | 1993-04-01 | — | — | WO | disclosed |
| EP-0345637-B1 | N-SUBSTITUTED 3,4,5,6-TETRAHYDROPHTHALIMIDE DERIVATIVES | BASF Aktiengesellschaft (DE) | 1993-03-17 | — | — | EP | disclosed |
| US-5106408-A | Pre- and postemergence | BASF AKTIENGESELLSCHAFT (DE) | 1992-04-21 | — | — | US | disclosed |
| EP-0414112-A2 | Herbicides thiadiazabicyclononan derivatives | BASF Aktiengesellschaft (DE) | 1991-02-27 | — | — | EP | disclosed |
| EP-0400427-A1 | Herbicidal 5-(N-3,4,5,6-tetrahydrophthalimido)-cinnamic acid esters, process for their preparation and their use | BASF Aktiengesellschaft (DE) | 1990-12-05 | — | — | EP | disclosed |
| US-4959098-A | HERBICIDES, PLANT GROWTH REGULATORS | BASF AKTIENGESELLSCHAFT (DE) | 1990-09-25 | — | — | US | disclosed |
| EP-0345637-A1 | N-substituted 3,4,5,6-tetrahydrophthalimide derivatives | BASF Aktiengesellschaft (DE) | 1989-12-13 | — | — | EP | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20010031865-A1 | Substituted 3-phenyluracils | CCR1, CCR6, CCR3 | CYP3A4 1383/4885TSHR 1263/4885MAPT 4647/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.